Findings suggest your 'microbial fingerprint' is important to well-being
The FDA will bar sales of e-cigarettes, cigars, and hookah tobacco to anyone under 18. WebMD has the details.
Both warfarin and the atrial fibrillation it's often used to treat may raise risk, study suggests
Researchers found slimmest people had lowest chances of dying in two studies
Whites with heart failure more likely to develop atrial fibrillation, research finds
PARIS/NEW YORK (Reuters) - France's Sanofi said it could raise its proposed $9.3 billion deal to buy Medivation if the U.S. cancer drugmaker engaged in talks, threatening to go directly to shareholders to oust the board if not. Sanofi Chief Executive Olivier Brandicourt wrote in a letter to the board of Medivation published on Thursday that the transaction was a priority for the French drugmaker and it was committed to seeing it through. San Francisco-based Medivation said on Thursday it had received a letter from Sanofi that "simply restates an inadequate proposal that... substantially undervalues the Company, its leading oncology franchise, and innovative late-stage pipeline".
Two rival cholesterol-lowering injections from Sanofi and Amgen have been recommended by Britain's healthcare cost watchdog after the manufacturers offered special discounts to the country's state-run health service. Sanofi's Praluent, which was developed with Regeneron, and Amgen's Repatha are both so-called PCSK9 medicines that work in a different way to existing cholesterol fighters such as statins. The National Institute for Health and Care Excellence (NICE) said in draft guidance on Friday that both drugs could be considered for use by people whose cholesterol is still not under control despite trying other treatments.
As I'm writing this article, it is 5:54am. I'm trying to tell myself that "I'm not a morning person" -- but this simply isn't the case anymore. If you are anything like me (or how I used to be), pressing the snooze button every morning was a ritual. "10 more minutes... 5 more minutes" -- these phrases were far too common for me every morning....
The United States Thursday issued a sweeping ban on sales of e-cigarettes, cigars, pipe tobacco and hookahs to those under 18, marking the first time these products have been federally regulated. The ban will go into effect in 90 days, according to the US Food and Drug Administration, which issued the final rule after several years of study and debate. Until now, the marketplace for tobacco products outside of traditional cigarettes has been like "the wild, wild west," said Mitch Zeller, director of the FDA's Center for Tobacco Products.
MIAMI (AP) — British biotech company Oxitec and the Cayman Islands government announced plans Thursday to release millions of genetically modified mosquitoes in the fight against a species that spreads Zika and other diseases.